The role for preimplantation genetic diagnosis in balanced translocation carriers

Jone E. Sampson, Nadia Ouhibi, Helen Lawce, Phillip Patton, David Battaglia, Kenneth A. Burry, Susan Olson

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective Preimplantation genetic diagnosis is an established technique that provides an alternative to prenatal diagnosis for patients who are at risk of transmitting a serious genetic disorder to their offspring. Preimplantation genetic diagnosis has been used for couples who have been at risk for having offspring with single gene or X-linked disorders and for screening for common age-related aneuploidy and in couples who themselves carry balanced chromosomal rearrangements. The aim of this study was to summarize our experience using preimplantation genetic diagnosis after the identification of a parental balanced translocation, specifically as it relates to the number of embryos that are suitable for transfer after preimplantation genetic diagnosis for a known translocation and aneuploidy screening. Study design This is a retrospective review of data from a single center that involved 6 couples that initiated the process of preimplantation genetic diagnosis for translocation and aneuploidy screening by fluorescent in situ hybridization. Results A total of 65 embryos were obtained, of which 56 embryos (86%) were suitable for fluorescent in situ hybridization analysis. After fluorescent in situ hybridization, 1 embryo was diagnosed as normal or balanced (1.7%). Forty-three embryos (76.8%) were unbalanced for the translocation; 8 embryos (14.3%) were aneuploid, and 4 embryos (7.1%) were uninformative. There were no clinical pregnancies. Conclusion In our experience, there are very few embryos that are available for transfer from these patients after translocation and aneuploidy screening because of multiple unbalanced segregation products and a high rate of aneuploidy. Factors that contributed to this may be related to which parent carries the translocation, methods that were used for in vitro fertilization, and advanced maternal age. Although preimplantation genetic diagnosis for translocation carriers theoretically can enhance the pregnancy rate for a couple, there are limitations. This information should be shared with couples who are contemplating preimplantation genetic diagnosis for translocation, and the options of sperm or egg donor should be considered.

Original languageEnglish (US)
Pages (from-to)1707-1713
Number of pages7
JournalAmerican Journal of Obstetrics and Gynecology
Volume190
Issue number6
DOIs
StatePublished - Jun 2004

Fingerprint

Preimplantation Diagnosis
Aneuploidy
Embryonic Structures
Genetic Translocation
Fluorescence In Situ Hybridization
Embryo Transfer
X-Linked Genes
Inborn Genetic Diseases
Maternal Age
Pregnancy Rate
Fertilization in Vitro
Prenatal Diagnosis
Ovum
Spermatozoa
Tissue Donors
Pregnancy

Keywords

  • Aneuploidy
  • Balanced translocation
  • Fluorescent in situ hybridization
  • Preimplantation genetic diagnosis

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

The role for preimplantation genetic diagnosis in balanced translocation carriers. / Sampson, Jone E.; Ouhibi, Nadia; Lawce, Helen; Patton, Phillip; Battaglia, David; Burry, Kenneth A.; Olson, Susan.

In: American Journal of Obstetrics and Gynecology, Vol. 190, No. 6, 06.2004, p. 1707-1713.

Research output: Contribution to journalArticle

Sampson, Jone E. ; Ouhibi, Nadia ; Lawce, Helen ; Patton, Phillip ; Battaglia, David ; Burry, Kenneth A. ; Olson, Susan. / The role for preimplantation genetic diagnosis in balanced translocation carriers. In: American Journal of Obstetrics and Gynecology. 2004 ; Vol. 190, No. 6. pp. 1707-1713.
@article{390f786fcada46b2ad2f15647435ac39,
title = "The role for preimplantation genetic diagnosis in balanced translocation carriers",
abstract = "Objective Preimplantation genetic diagnosis is an established technique that provides an alternative to prenatal diagnosis for patients who are at risk of transmitting a serious genetic disorder to their offspring. Preimplantation genetic diagnosis has been used for couples who have been at risk for having offspring with single gene or X-linked disorders and for screening for common age-related aneuploidy and in couples who themselves carry balanced chromosomal rearrangements. The aim of this study was to summarize our experience using preimplantation genetic diagnosis after the identification of a parental balanced translocation, specifically as it relates to the number of embryos that are suitable for transfer after preimplantation genetic diagnosis for a known translocation and aneuploidy screening. Study design This is a retrospective review of data from a single center that involved 6 couples that initiated the process of preimplantation genetic diagnosis for translocation and aneuploidy screening by fluorescent in situ hybridization. Results A total of 65 embryos were obtained, of which 56 embryos (86{\%}) were suitable for fluorescent in situ hybridization analysis. After fluorescent in situ hybridization, 1 embryo was diagnosed as normal or balanced (1.7{\%}). Forty-three embryos (76.8{\%}) were unbalanced for the translocation; 8 embryos (14.3{\%}) were aneuploid, and 4 embryos (7.1{\%}) were uninformative. There were no clinical pregnancies. Conclusion In our experience, there are very few embryos that are available for transfer from these patients after translocation and aneuploidy screening because of multiple unbalanced segregation products and a high rate of aneuploidy. Factors that contributed to this may be related to which parent carries the translocation, methods that were used for in vitro fertilization, and advanced maternal age. Although preimplantation genetic diagnosis for translocation carriers theoretically can enhance the pregnancy rate for a couple, there are limitations. This information should be shared with couples who are contemplating preimplantation genetic diagnosis for translocation, and the options of sperm or egg donor should be considered.",
keywords = "Aneuploidy, Balanced translocation, Fluorescent in situ hybridization, Preimplantation genetic diagnosis",
author = "Sampson, {Jone E.} and Nadia Ouhibi and Helen Lawce and Phillip Patton and David Battaglia and Burry, {Kenneth A.} and Susan Olson",
year = "2004",
month = "6",
doi = "10.1016/j.ajog.2004.02.063",
language = "English (US)",
volume = "190",
pages = "1707--1713",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - The role for preimplantation genetic diagnosis in balanced translocation carriers

AU - Sampson, Jone E.

AU - Ouhibi, Nadia

AU - Lawce, Helen

AU - Patton, Phillip

AU - Battaglia, David

AU - Burry, Kenneth A.

AU - Olson, Susan

PY - 2004/6

Y1 - 2004/6

N2 - Objective Preimplantation genetic diagnosis is an established technique that provides an alternative to prenatal diagnosis for patients who are at risk of transmitting a serious genetic disorder to their offspring. Preimplantation genetic diagnosis has been used for couples who have been at risk for having offspring with single gene or X-linked disorders and for screening for common age-related aneuploidy and in couples who themselves carry balanced chromosomal rearrangements. The aim of this study was to summarize our experience using preimplantation genetic diagnosis after the identification of a parental balanced translocation, specifically as it relates to the number of embryos that are suitable for transfer after preimplantation genetic diagnosis for a known translocation and aneuploidy screening. Study design This is a retrospective review of data from a single center that involved 6 couples that initiated the process of preimplantation genetic diagnosis for translocation and aneuploidy screening by fluorescent in situ hybridization. Results A total of 65 embryos were obtained, of which 56 embryos (86%) were suitable for fluorescent in situ hybridization analysis. After fluorescent in situ hybridization, 1 embryo was diagnosed as normal or balanced (1.7%). Forty-three embryos (76.8%) were unbalanced for the translocation; 8 embryos (14.3%) were aneuploid, and 4 embryos (7.1%) were uninformative. There were no clinical pregnancies. Conclusion In our experience, there are very few embryos that are available for transfer from these patients after translocation and aneuploidy screening because of multiple unbalanced segregation products and a high rate of aneuploidy. Factors that contributed to this may be related to which parent carries the translocation, methods that were used for in vitro fertilization, and advanced maternal age. Although preimplantation genetic diagnosis for translocation carriers theoretically can enhance the pregnancy rate for a couple, there are limitations. This information should be shared with couples who are contemplating preimplantation genetic diagnosis for translocation, and the options of sperm or egg donor should be considered.

AB - Objective Preimplantation genetic diagnosis is an established technique that provides an alternative to prenatal diagnosis for patients who are at risk of transmitting a serious genetic disorder to their offspring. Preimplantation genetic diagnosis has been used for couples who have been at risk for having offspring with single gene or X-linked disorders and for screening for common age-related aneuploidy and in couples who themselves carry balanced chromosomal rearrangements. The aim of this study was to summarize our experience using preimplantation genetic diagnosis after the identification of a parental balanced translocation, specifically as it relates to the number of embryos that are suitable for transfer after preimplantation genetic diagnosis for a known translocation and aneuploidy screening. Study design This is a retrospective review of data from a single center that involved 6 couples that initiated the process of preimplantation genetic diagnosis for translocation and aneuploidy screening by fluorescent in situ hybridization. Results A total of 65 embryos were obtained, of which 56 embryos (86%) were suitable for fluorescent in situ hybridization analysis. After fluorescent in situ hybridization, 1 embryo was diagnosed as normal or balanced (1.7%). Forty-three embryos (76.8%) were unbalanced for the translocation; 8 embryos (14.3%) were aneuploid, and 4 embryos (7.1%) were uninformative. There were no clinical pregnancies. Conclusion In our experience, there are very few embryos that are available for transfer from these patients after translocation and aneuploidy screening because of multiple unbalanced segregation products and a high rate of aneuploidy. Factors that contributed to this may be related to which parent carries the translocation, methods that were used for in vitro fertilization, and advanced maternal age. Although preimplantation genetic diagnosis for translocation carriers theoretically can enhance the pregnancy rate for a couple, there are limitations. This information should be shared with couples who are contemplating preimplantation genetic diagnosis for translocation, and the options of sperm or egg donor should be considered.

KW - Aneuploidy

KW - Balanced translocation

KW - Fluorescent in situ hybridization

KW - Preimplantation genetic diagnosis

UR - http://www.scopus.com/inward/record.url?scp=3442881647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3442881647&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2004.02.063

DO - 10.1016/j.ajog.2004.02.063

M3 - Article

C2 - 15284776

AN - SCOPUS:3442881647

VL - 190

SP - 1707

EP - 1713

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -